Apologies if this has been posted or discussed previously as I don't have the time to keep up with all the posts here lately. This point in motley fool's advertising, "It points out that the timing of the correspondence coincides with refreshed leadership at the newly formed Office of Therapeutic Products at the FDA." I wasn't aware of this?
Mesoblast Ltd (ASX: MSB)
Another note out of Bell Potter reveals that its analysts have retained their speculative buy rating on this biotechnology company's shares with a significantly improved price target of $1.40 (from 58 cents previously). Bell Potter notes that the FDA has used carefully chosen words to inform Mesoblast that the available clinical data from its Phase 3 study MSB-GvHD001 in children with steroid refractory acute graft versus host disease (SR a GvHD) appears sufficient to support a resubmission of the Biological Licence Application (BLA) for Remestemcel. It points out that the timing of the correspondence coincides with refreshed leadership at the newly formed Office of Therapeutic Products at the FDA. In light of this, the broker has renewed confidence for a prospective approval for Remestemcel later this year. It feels that a first approval may represent a gateway to a series of label expansions in the ensuing period. The Mesoblast share price is fetching 86.7 cents on Friday."
Bold highlight is mine.
- Forums
- ASX - By Stock
- MSB
- banter and General Discussion
banter and General Discussion, page-9394
-
- There are more pages in this discussion • 297 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.13 |
Change
0.050(4.65%) |
Mkt cap ! $1.284B |
Open | High | Low | Value | Volume |
$1.08 | $1.13 | $1.07 | $5.964M | 5.444M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 25000 | $1.11 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.13 | 176236 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 25000 | 1.110 |
2 | 149752 | 1.100 |
1 | 16932 | 1.095 |
1 | 16932 | 1.090 |
1 | 16932 | 1.085 |
Price($) | Vol. | No. |
---|---|---|
1.130 | 176236 | 7 |
1.135 | 72500 | 2 |
1.140 | 41258 | 4 |
1.145 | 14746 | 2 |
1.150 | 18885 | 5 |
Last trade - 16.10pm 21/05/2024 (20 minute delay) ? |
|
|||||
Last
$1.12 |
  |
Change
0.050 ( 4.69 %) |
|||
Open | High | Low | Volume | ||
$1.09 | $1.13 | $1.07 | 829227 | ||
Last updated 15.59pm 21/05/2024 ? |
Featured News
MSB (ASX) Chart |
The Watchlist
AUQ
ALARA RESOURCES LIMITED
Stephen Gethin, Non-Executive Director & Chairman
Stephen Gethin
Non-Executive Director & Chairman
Previous Video
Next Video
SPONSORED BY The Market Online